MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Biocon
Biocon
BSE: 532523|NSE: BIOCON|ISIN: INE376G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 31, 17:00
220.65
1.2 (0.55%)
VOLUME 29,363
LIVE
NSE
May 31, 17:00
220.55
0.45 (0.2%)
VOLUME 321,307
Management Interviews on Biocon
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
No short-term revenue impact from split with Pfizer: Biocon 

10.50 am | 13 Mar 2012 |  Source: CNBC-TV18

In an exclusive interview to CNBC-TV18, Kiran Mazumdar Shaw of Biocon says that the breakup with Pfizer will not have any short-term impact on revenue...

Biocon-Pfizer insulin deal might collapse soon: PharmAsia 

9.59 pm | 12 Mar 2012 |  Source: CNBC-TV18

The deal between Biocon and Pfizer to market a range of insulin products may be in crisis. Vikas Dandekar, the India Bureau Chief of PharmAsia News wh...

1
Quick Links for Biocon
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.